Sunshine Biopharma (SBFM) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Sunshine Biopharma (SBFM) over the last 10 years, with Q3 2025 value amounting to $4.2 million.
- Sunshine Biopharma's Receivables - Net rose 2910.87% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 2910.87%. This contributed to the annual value of $3.9 million for FY2024, which is 5156.23% up from last year.
- Latest data reveals that Sunshine Biopharma reported Receivables - Net of $4.2 million as of Q3 2025, which was up 2910.87% from $3.6 million recorded in Q2 2025.
- Sunshine Biopharma's 5-year Receivables - Net high stood at $4.2 million for Q3 2025, and its period low was $22.0 during Q3 2022.
- In the last 5 years, Sunshine Biopharma's Receivables - Net had a median value of $2.0 million in 2023 and averaged $2.1 million.
- In the last 5 years, Sunshine Biopharma's Receivables - Net crashed by 9805.14% in 2022 and then soared by 924589545.45% in 2023.
- Quarter analysis of 5 years shows Sunshine Biopharma's Receivables - Net stood at $7798.0 in 2021, then skyrocketed by 24421.07% to $1.9 million in 2022, then skyrocketed by 33.48% to $2.6 million in 2023, then skyrocketed by 51.56% to $3.9 million in 2024, then increased by 7.42% to $4.2 million in 2025.
- Its Receivables - Net was $4.2 million in Q3 2025, compared to $3.6 million in Q2 2025 and $3.4 million in Q1 2025.